TherapeuticsMD (TXMD) Notes Payables (2010 - 2022)
TherapeuticsMD (TXMD) posted Notes Payables of $1.8 million for Q3 2022, up 1067.33% on a QoQ basis from $150000.0 in Q3 2012.
TherapeuticsMD (TXMD) Notes Payables (2010 - 2022) Analysis & Trends
TherapeuticsMD's Notes Payables history runs 4 years deep, the most recent figure standing at $1.8 million for Q3 2022.
- Quarterly Notes Payables changed N/A year-over-year to $1.8 million in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $1.8 million (changed N/A YoY) and the FY2011 annual result came in at $200000.0, down 63.2% from the prior year.
- Notes Payables was $1.8 million for Q3 2022 at TherapeuticsMD, up from $150000.0 in the prior quarter.
- Across five years, Notes Payables topped out at $1.8 million in Q3 2022 and bottomed at $1.8 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1.75 Mn |
| Sep 30, 2012 | 150,000.00 |
| Jun 30, 2012 | 150,000.00 |
| Mar 31, 2012 | 200,000.00 |
| Dec 31, 2011 | 200,000.00 |
| Jun 30, 2011 | 99,000.00 |
| Dec 31, 2010 | 543,531.00 |